GENEMATRIX
| WVB Number : KOR000040597 | Country : Republic of Korea |
| SIC categorization : COML PHYSICAL, BIOLOGCL RESH (8731) | ISIN : KR7109820001 |
| FT categorization : DIV'D HEALTH & PERSONAL CARE (430) | |
| Company status: ACTIVE |
» Corporation Profile :
| Profile in brief: The Company is a Korea-based biotechnology company. The Company mainly develops restriction fragment mass polymorphisms (RFMP) clinical diagnostic systems, RFMP molecular markers, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) theranostics systems, molecular diagnostic platforms, and systems for microorganism identification. |
|
| Phone : 82 031 628 2000 | Fax : 031 628 2002 |
| Chairman: : N/A | Auditor : SAMIL PRICEWATERHOUSE COOPERS |
| CEO/Managing Director : WANG DON YOO | |
» Company Facts
| Net Profit Margin (%) | -28.32 |
| Operating Margin (%) | -31.55 |
| Return on Assets (%) | -7.93 |
| Return on Equity (%) | -11.51 |
| Employees | 15 |
» Company Financials
| Annual (2017) | |
| Income Statement ('000 KRW ) |
|
| Sales/Total Revenue | 5,189,163 |
| EBITDA | -1,431,650 |
| EBIT | -1,762,136 |
| Net Income | -1,469,764 |
| Balance Sheet ( '000 KRW) |
|
| Total Current Assets | 11,080,946 |
| Total Assets | 17,743,477 |
| Current Liabilities | 5,025,483 |
| Total Liabilities & Debt | 5,798,348 |
| Total Equity | 11,945,129 |
| Cash & Flow ( '000 KRW) |
|
| Net Income/Staring Line | -1,734,513 |
| Cash from Operating | -1,773,701 |
| Cash from Investing | 1,726,614 |
| Cash from Financing | 90,879 |
| Cash & Equivalent Yr End | 1,262,785 |